Distribution, Licensing and Collaboration Arrangements (Details Textual) - USD ($)	1 Months Ended
	May 31, 2016	Jan. 31, 2015	May 22, 2016	Dec. 31, 2013
Distribution And Licensing Agreements [Line Items]
Advance Royalties				$ 5,000,000
Boyalife Distribution Agreement
Distribution And Licensing Agreements [Line Items]
License Fee Payment Description	(a) $500,000 within 90 days of approval of the Aurix Products by the China Food and Drug Administration (“CFDA”), but no earlier than December 31, 2018, and (b) a distribution fee per wound dressing kit and reagent kit of $40, payable quarterly
License Agreement Term	5 years
Boyalife Distribution Agreement | Maximum [Member]
Distribution And Licensing Agreements [Line Items]
Exchange Payment To Be Made In Exercisable Of Contract	$ 250,000
Restorix Distribution Agreement [Member]
Distribution And Licensing Agreements [Line Items]
Reduction In Allowed Claim	$ 15,000,000
Current Product Price			$ 700
Restorix Distribution Agreement [Member] | Maximum [Member]
Distribution And Licensing Agreements [Line Items]
Current Product Price			$ 750
Millennia Holdings, Inc [Member]
Distribution And Licensing Agreements [Line Items]
Payments for Terminated Licenses		$ 1,500,000
Rohto Pharmaceutical Co., Ltd [Member]
Distribution And Licensing Agreements [Line Items]
Proceeds from License Fees Received		$ 3,000,000